Smith and Nephew lifts outlook as medical device revenue growth offsets China slowdown
Smith and Nephew, the medical technology business reported steady revenue today growth despite ‘headwinds’ in China slowing down its 12-point growth plan. The FTSE 100-listed firm said its fourth-quarter revenue…